Page last updated: 2024-12-08

sodium (trans-rucl4(dmso)im)

Description

dimethylsulfoxideimidazoletetrachlororuthenate(III): structure given in first source ; RN refers to the sodium cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID164388
MeSH IDM0203399

Synonyms (14)

Synonym
135908-84-8
dimethylsulfoxideimidazoletetrachlororuthenate(iii)
ruthenate(1-), tetrachloro(1h-imidazole-n3)(sulfinylbis(methane)-s)-, sodium, (oc-6-11)-
ruthenate(1-), tetrachloro(1h-imidazole-kappan3)((sulfinyl-kappas)bis(methane))-, sodium, (oc-6-11)-
dimethylsulfoxideimidazoletetrachlorouthenate (iii), sodium
unii-vo01lm7031
sodium (trans-rucl4(dmso)im)
na(trans-rucl4(dmso)im)
vo01lm7031 ,
nami
ruthenate(1-), tetrachloro(1h-imidazole-.kappa.n3)(1,1'-(sulfinyl-.kappa.s)bis(methane))-, sodium (1:1), (oc-6-11)-
ruthenate(1-), tetrachloro(1h-imidazole-.kappa.n3)((sulfinyl-.kappa.s)bis(methane))-, sodium, (oc-6-11)-
nami-a sodium
sodium;1h-imidazole;methylsulfinylmethane;ruthenium(3+);tetrachloride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (87.50)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
chemdatabank.com